Integrase (IN) catalyzes the insertion of the viral DNA (vDNA) into host cell chromosomes. IN represents an attractive target for antiretroviral (ARVs) drugs and has been the object of intensive
classification of alpha, beta and residues of HIV ribonuclease, HIV reverse transcriptase, protease, integrase, and these four types of HIV enzymes are present in HIV1 & HIV2 cycle. Various machine learning ... been…
methanol extracts of medicinal plants for activity against HIV-1 reverse transcriptase (RT) and integrase (IN). The n-butanol fraction obtained from the crude methanol extracts of the roots ... However, it had no…
recent drug to be approved for use in HIV therapy is dolutegravir, an HIV integrase inhibitor, that was approved for therapy by the Food and Drug Administration in the United ... hypothesized that this is due to the…
This compilation highlights current research in HIV-1, focusing on novel therapeutic agents like integrase inhibitors and broadlyneutralizing antibodies. It examines host immune responses in elite controllers, the…
iodine is significant for activity of compounds that inhibit the situation of HIV-1 integrase. Iodine prevents the situation of integrase from the formation of with HIV deoxyribonucleic acid ... inhibits the active…
iodine is significant for activity of compounds that inhibit the situation of HIV-1 integrase. Iodine prevents the situation of integrase from the formation of with HIV deoxyribonucleic acid ... inhibits the active…
iodine is significant for activity of compounds that inhibit the situation of HIV-1 integrase. Iodine prevents the situation of integrase from the formation of with HIV deoxyribonucleic acid ... inhibits the active…
Dolutegravir, a second-generation HIV Integrase Strand Transfer Inhibitor (INSTI), is the most current antiretroviral ratified for treatment of HIV-1 infection. This approval is based on the superiority
naturally occurring carbapenemase gene intrinsic in this species. Presence of class 1 integrase gene in Acinetobacter isolates is a useful marker for causing outbreaks in hospitals and for being epidemic ... genes by…
reverse transcriptase inhibitors, Protease Inhibitors, Nucleoside reverse transcriptase inhibitors, Entry and Fusion Inhibitors and Integrase inhibitors have been documented to cause adverse effects in patients…
based 2nd line regimen. Methods: Bulk sequencing of HIV-1 protease, reverse transcriptase and integrase PCR products. Results: Protease gene amplification was successful for 71/89 patients (80%). All were
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.